Does aspirin use reduce cardiovascular risk in diabetes?
John A Colwell
Nature Reviews. Endocrinology 2009, 5 (4): 188-90
19352314
The use of aspirin for the primary prevention of cardiovascular events in patients with type 2 diabetes mellitus is controversial. According to the findings of a Japanese trial, aspirin does not reduce the risk of cardiovascular events in this group of patients, unless they are aged 65 years and above.
Full Text Links
Find Full Text Links for this Article
You are not logged in. Sign Up or Log In to join the discussion.